Abstract
Background.
In the Fluid Expansion as a Supportive Treatment (FEAST) trial, an unexpectedly high proportion of participants from eastern Uganda presented with blackwater fever (BWF).
Methods.
We describe the prevalence and outcome of BWF among trial participants and compare the prevalence of 3 malar- ia-protective red blood cell polymorphisms in BWF cases vs both trial (non-BWF) and population controls. Results. Of 3170 trial participants, 394 (12.4%) had BWF. The majority (318 [81.0%]) presented in eastern Uganda and were the subjects of further analysis. BWF cases typically presented with both clinical jaundice (254/318 [80%]) and severe anemia (hemoglo- bin level
Conclusions.
We report the emergence of BWF in eastern Uganda, a condition that, according to local investigators, was rare until the last 7 years. We speculate that this might relate to the introduction of artemisinin-based combination therapies. Further studies investigating this possibility are urgently required.
Original language | Undefined/Unknown |
---|---|
Journal | Paediatrics and Child Health, East Africa |
DOIs | |
Publication status | Published - 1 Apr 2017 |